Therapeutic Apheresis

Therapeutic Apheresis

1 apheresis . The advent of sophisticated blood cell separators (Figure 1) has dramatically changed the application of apheresis with increasingly specific blood cells being targeted. This technology is now used in both the donor setting for the collection of blood product and in the therapeutic application for the treatment of many disease processes. The technique of apheresis has been develop...

Therapeutic Apheresis in Dyslipidemia

In the last decades, LDL apheresis was introduced as an extracorporeal treatment option for patients with homozygous or severe heterozygous familial hypercholesterolemia. The prognosis of patients suffering from severe dyslipidemia, sometimes combined with elevated lipoprotein (a) levels, and coronary heart disease refractory to diet and lipid-lowering drugs is poor. For such patients, regular ...

Therapeutic apheresis in nephrology

Therapeutic plasma exchange (TPE) with hollow fiber modules is used in different severe diseases since more than 35 years. Based on many years of experience with the extracorporeal circulation in end-stage renal disease, the authors try to give an overview of therapeutic apheresis (TA) in renal diseases. The updated information on immunology and molecular biology of different renal diseases are...

Clinical applications of therapeutic apheresis.

Rasheed A. Balogun,* Andre Kaplan, David M. Ward, Chidi Okafor, Ted M. Burns, A. Sergio Torloni, B. Gail Macik, and Emaad M. Abdel-Rahman Department of Medicine, Division of Nephrology, University of Virginia Health System, Charlottesville, Virginia Department of Medicine, University of Connecticut Health Center, Farmington, Connecticut Department of Medicine, University of California, San Dieg...

Where now for therapeutic apheresis?